∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods
Published by Oxford University Press 2023. This work is written by (a) US Government employee(s) and is in the public domain in the US..
Because of structural similarities, the presence of 11-Nor-9-carboxy-∆8-tetrahydrocannabinol (∆8-THC-COOH) in a urine specimen might interfere with testing for 11-Nor-9-carboxy-∆9-tetrahydrocannabinol (∆9-THC-COOH). A set of samples containing ∆8-THC-COOH with concentrations ranging from 10 to 120 ng/mL were tested at cut-offs of 20, 50 and 100 ng/mL using cannabinoid immunoassay reagents from three different manufacturers. Cross-reactivities ranged from 87% to 112% for ∆8-THC-COOH at the cut-off of 50 ng/mL for the three different platforms. Additionally, samples containing both ∆8-THC-COOH and ∆9-THC-COOH were fortified by the National Laboratory Certification Program (NLCP). U.S. Department of Health and Human Services (HHS)-Certified Laboratories tested the samples to determine the interference of ∆8-THC-COOH on confirmatory tests commonly used in workplace drug testing laboratories for the confirmation and quantification of ∆9-THC-COOH. When evaluating confirmation and quantification of ∆9-THC-COOH in the presence of ∆8-THC-COOH, unreportable results for ∆9-THC-COOH were observed because of chromatographic interference or mass ratio failures. However, there were no false-positive ∆9-THC-COOH reports from any HHS-certified laboratory.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Journal of analytical toxicology - 47(2023), 7 vom: 15. Sept., Seite 557-562 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mullen, Lawrance D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 18.09.2023 Date Revised 18.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jat/bkad042 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35906857X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35906857X | ||
| 003 | DE-627 | ||
| 005 | 20231226080102.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jat/bkad042 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1196.xml |
| 035 | |a (DE-627)NLM35906857X | ||
| 035 | |a (NLM)37405696 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mullen, Lawrance D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.09.2023 | ||
| 500 | |a Date Revised 18.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Oxford University Press 2023. This work is written by (a) US Government employee(s) and is in the public domain in the US. | ||
| 520 | |a Because of structural similarities, the presence of 11-Nor-9-carboxy-∆8-tetrahydrocannabinol (∆8-THC-COOH) in a urine specimen might interfere with testing for 11-Nor-9-carboxy-∆9-tetrahydrocannabinol (∆9-THC-COOH). A set of samples containing ∆8-THC-COOH with concentrations ranging from 10 to 120 ng/mL were tested at cut-offs of 20, 50 and 100 ng/mL using cannabinoid immunoassay reagents from three different manufacturers. Cross-reactivities ranged from 87% to 112% for ∆8-THC-COOH at the cut-off of 50 ng/mL for the three different platforms. Additionally, samples containing both ∆8-THC-COOH and ∆9-THC-COOH were fortified by the National Laboratory Certification Program (NLCP). U.S. Department of Health and Human Services (HHS)-Certified Laboratories tested the samples to determine the interference of ∆8-THC-COOH on confirmatory tests commonly used in workplace drug testing laboratories for the confirmation and quantification of ∆9-THC-COOH. When evaluating confirmation and quantification of ∆9-THC-COOH in the presence of ∆8-THC-COOH, unreportable results for ∆9-THC-COOH were observed because of chromatographic interference or mass ratio failures. However, there were no false-positive ∆9-THC-COOH reports from any HHS-certified laboratory | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Cannabinoids |2 NLM | |
| 650 | 7 | |a Dronabinol |2 NLM | |
| 650 | 7 | |a 7J8897W37S |2 NLM | |
| 700 | 1 | |a Hart, E Dale |e verfasserin |4 aut | |
| 700 | 1 | |a Vikingsson, Svante |e verfasserin |4 aut | |
| 700 | 1 | |a Winecker, Ruth E |e verfasserin |4 aut | |
| 700 | 1 | |a Hayes, Eugene |e verfasserin |4 aut | |
| 700 | 1 | |a Flegel, Ron |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of analytical toxicology |d 1980 |g 47(2023), 7 vom: 15. Sept., Seite 557-562 |w (DE-627)NLM012646741 |x 1945-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2023 |g number:7 |g day:15 |g month:09 |g pages:557-562 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jat/bkad042 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2023 |e 7 |b 15 |c 09 |h 557-562 | ||